- Home
- WHD vs GH Comparison
WHD vs GH Comparison
Compare WHD & GH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WHD
- GH
- Stock Information
- Founded
- WHD 2011
- GH 2011
- Country
- WHD United States
- GH United States
- Employees
- WHD N/A
- GH N/A
- Industry
- WHD Metal Fabrications
- GH Medical Specialities
- Sector
- WHD Industrials
- GH Health Care
- Exchange
- WHD Nasdaq
- GH Nasdaq
- Market Cap
- WHD 3.8B
- GH 4.3B
- IPO Year
- WHD 2018
- GH 2018
- Fundamental
- Price
- WHD $60.38
- GH $37.46
- Analyst Decision
- WHD Hold
- GH Strong Buy
- Analyst Count
- WHD 6
- GH 14
- Target Price
- WHD $56.40
- GH $39.93
- AVG Volume (30 Days)
- WHD 575.8K
- GH 1.8M
- Earning Date
- WHD 02-26-2025
- GH 02-20-2025
- Dividend Yield
- WHD 0.86%
- GH N/A
- EPS Growth
- WHD 21.87
- GH N/A
- EPS
- WHD 2.84
- GH N/A
- Revenue
- WHD $1,132,559,000.00
- GH $692,256,000.00
- Revenue This Year
- WHD $4.29
- GH $32.21
- Revenue Next Year
- WHD $3.23
- GH $16.90
- P/E Ratio
- WHD $21.29
- GH N/A
- Revenue Growth
- WHD 12.15
- GH 29.20
- 52 Week Low
- WHD $37.58
- GH $15.81
- 52 Week High
- WHD $70.01
- GH $39.29
- Technical
- Relative Strength Index (RSI)
- WHD 48.57
- GH 66.67
- Support Level
- WHD $58.57
- GH $34.80
- Resistance Level
- WHD $61.85
- GH $37.46
- Average True Range (ATR)
- WHD 1.57
- GH 1.78
- MACD
- WHD 0.43
- GH 0.51
- Stochastic Oscillator
- WHD 75.04
- GH 80.49
About WHD Cactus Inc.
Cactus Inc is engaged in the designing, manufacturing, and sale of wellheads and pressure control equipment. Its principal products include Cactus SafeDrill wellhead systems, conventional wellheads, and production valves among others. The company also provides mission-critical field services, including service crews to assist with the installation, maintenance, and safe handling of the wellhead and pressure control equipment, as well as repair services for equipment that it sells or rents. It sells or rents its products principally for onshore unconventional oil and gas wells that are utilized during the drilling, completion (including fracturing), and production. The company has two operating segments; Pressure Control , which generates key revenue and Spoolable Technologies.
About GH Guardant Health Inc.
Guardant Health, Inc, based in Redwood City, California, is a leader in liquid-based cancer tests for clinical and research use. The company offers Guardant360 LDT, a liquid biopsy test for treatment selection in advanced stage cancer, Guardant360 CDx, an FDA-approved companion diagnostic for several targeted therapies, and Guardant OMNI, a broader gene panel for immuno-oncology research. In 2021, Guardant launched Reveal, a tumor-agnostic molecular residual disease, or MRD, test. In 2022, the company launched a lab-developed test version of Shield, a liquid biopsy for colorectal cancer, or CRC, screening. Additionally, Guardant offers research development services such as regulatory approval consultancy and clinical trial referrals.